MY162697A - Methods, devices and kits for detecting or monitoring acute kidney injury - Google Patents
Methods, devices and kits for detecting or monitoring acute kidney injuryInfo
- Publication number
- MY162697A MY162697A MYPI2011002257A MYPI2011002257A MY162697A MY 162697 A MY162697 A MY 162697A MY PI2011002257 A MYPI2011002257 A MY PI2011002257A MY PI2011002257 A MYPI2011002257 A MY PI2011002257A MY 162697 A MY162697 A MY 162697A
- Authority
- MY
- Malaysia
- Prior art keywords
- ngal
- sample
- methods
- antibody
- kidney injury
- Prior art date
Links
- 208000009304 Acute Kidney Injury Diseases 0.000 title abstract 3
- 208000033626 Renal failure acute Diseases 0.000 title abstract 3
- 201000011040 acute kidney failure Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000012544 monitoring process Methods 0.000 title 1
- 102000013519 Lipocalin-2 Human genes 0.000 abstract 10
- 108010051335 Lipocalin-2 Proteins 0.000 abstract 10
- 238000003556 assay Methods 0.000 abstract 2
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 230000000536 complexating effect Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11671308P | 2008-11-21 | 2008-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY162697A true MY162697A (en) | 2017-07-14 |
Family
ID=41611201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2011002257A MY162697A (en) | 2008-11-21 | 2009-11-23 | Methods, devices and kits for detecting or monitoring acute kidney injury |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9476880B2 (OSRAM) |
| EP (2) | EP3141904B1 (OSRAM) |
| JP (1) | JP5438770B2 (OSRAM) |
| KR (2) | KR20190006614A (OSRAM) |
| CN (1) | CN102292637B (OSRAM) |
| AU (1) | AU2009318813B2 (OSRAM) |
| CA (1) | CA2744434C (OSRAM) |
| ES (1) | ES2718731T3 (OSRAM) |
| IL (1) | IL212988A (OSRAM) |
| MY (1) | MY162697A (OSRAM) |
| RU (1) | RU2519722C2 (OSRAM) |
| WO (1) | WO2010058378A1 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE539351T1 (de) | 2006-05-30 | 2012-01-15 | Antibodyshop As | Verfahren zur schnellen beurteilung der schwere eines traumas |
| EP2137538B1 (en) | 2007-03-21 | 2014-04-09 | Bioporto Diagnostics A/s | Diagnostic test for renal injury |
| US8846036B2 (en) | 2007-10-19 | 2014-09-30 | Abbott Laboratories | Antibodies that bind to mammalian NGAL and uses thereof |
| US8394606B2 (en) * | 2008-11-05 | 2013-03-12 | Abbott Laboratories | Neutrophil gelatinase-associated lipocalin (NGAL) protein isoforms enriched from urine and recombinant chinese hamster ovary (CHO) cells and related compositions, antibodies, and methods of enrichment, analysis and use |
| EP2568291A1 (en) * | 2011-09-07 | 2013-03-13 | Roche Diagnostics GmbH | L-FABP based diagnosis of kidney injury after an acute event or after a surgical intervention |
| PH12014500650A1 (en) * | 2011-09-22 | 2014-06-02 | Univ Los Andes | Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage |
| EP3361260B1 (en) * | 2012-10-02 | 2020-06-10 | sphingotec GmbH | A method for diagnosing or monitoring kidney function |
| CN102928606B (zh) * | 2012-11-16 | 2015-10-07 | 武汉明德生物科技股份有限公司 | 多抗体标记的降钙素原快速检测试剂盒 |
| MA38171B1 (fr) * | 2012-12-20 | 2017-07-31 | Novartis Ag | Évaluation du risque d’insuffisance rénale aiguë suite a une chirurgie cardiaque |
| US9488663B2 (en) | 2013-03-14 | 2016-11-08 | Abbott Point Of Care Inc. | Electrochemical methods and devices for amending urine samples for immunosensor detection |
| US9651547B2 (en) | 2013-03-14 | 2017-05-16 | Abbott Point Of Care Inc. | Electrochemical methods and devices for amending urine samples for immunosensor detection |
| JP6553020B2 (ja) | 2013-03-15 | 2019-07-31 | ジーピービー デット ホールディングス トゥー エルエルシー | アレルギー及び自己免疫疾患に関する診断分析を行うための自動化された免疫分析計システム |
| RU2566709C2 (ru) * | 2013-12-16 | 2015-10-27 | Владимир Борисович Бородулин | Способ ранней диагностики хронической болезни почек |
| CN107003320B (zh) * | 2014-11-25 | 2021-08-17 | 豪夫迈·罗氏有限公司 | 慢性肾脏疾病的快速进展的生物标志物 |
| CN104479015A (zh) * | 2014-12-04 | 2015-04-01 | 东南大学 | 针对ngal表位的纳米抗体及其应用 |
| CN105911274A (zh) * | 2016-06-12 | 2016-08-31 | 吉林大学 | 一种同步定量检测不同分子形式人中性粒细胞脂质运载蛋白免疫层析装置及其制备方法 |
| CN108802402A (zh) * | 2018-06-15 | 2018-11-13 | 重庆大学 | 一种快速鉴别呼吸道感染类型的试剂盒及其应用 |
| SE2430014A1 (en) * | 2024-01-18 | 2025-05-27 | P & M Venge Ab | Urinary biomarker of kidney function |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9401351D0 (sv) | 1994-04-21 | 1994-04-21 | Venge | A method for diagnosis |
| AU2002211697B2 (en) * | 2000-10-13 | 2005-12-15 | Children's Medical Center Corporation | Non-invasive enzyme screen for tissue remodelling-associated conditions |
| US7056702B2 (en) * | 2002-12-16 | 2006-06-06 | Kimberly Clark Co | Detecting lipocalin |
| CN1791797A (zh) * | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
| BRPI0408802B8 (pt) * | 2003-03-27 | 2021-07-27 | Childrens Hospital Med Ct | método para a detecção de uma lesão de célula tubular renal isquêmica e método para identificar a extensão desta lesão |
| CN101010001A (zh) * | 2004-05-06 | 2007-08-01 | 哥伦比亚大学受托人 | Ngal用于减少和改善局部缺血和肾中毒损伤 |
| US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| WO2005107793A2 (en) * | 2004-05-06 | 2005-11-17 | The Trustees Of Columbia University | Ngal for reduction and amelioration of ischemic and nephrotoxic injuries |
| ES2622467T3 (es) * | 2004-12-20 | 2017-07-06 | Antibodyshop A/S | Determinación de lipocalina asociada a gelatinasa de neutrófilos (NGAL) como marcador diagnóstico para trastornos renales |
| US20070037232A1 (en) | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
| US20080090304A1 (en) | 2006-10-13 | 2008-04-17 | Barasch Jonathan Matthew | Diagnosis and monitoring of chronic renal disease using ngal |
| WO2007098102A2 (en) * | 2006-02-17 | 2007-08-30 | Children's Medical Center Corporation | Free ngal as a biomarker for cancer |
| WO2009052390A1 (en) * | 2007-10-19 | 2009-04-23 | Abbott Laboratories | Glycosylated mammalian ngal and use thereof |
| US20090123970A1 (en) * | 2007-10-19 | 2009-05-14 | Abbott Laboratories | Glycosylated mammalian ngal and use thereof |
| CN101910845A (zh) * | 2007-11-15 | 2010-12-08 | 比奥波托诊断股份公司 | 个体分子形式的生物标志的诊断用途 |
-
2009
- 2009-11-23 JP JP2011537003A patent/JP5438770B2/ja not_active Expired - Fee Related
- 2009-11-23 MY MYPI2011002257A patent/MY162697A/en unknown
- 2009-11-23 EP EP16191697.8A patent/EP3141904B1/en not_active Not-in-force
- 2009-11-23 KR KR1020197001145A patent/KR20190006614A/ko not_active Ceased
- 2009-11-23 WO PCT/IB2009/055299 patent/WO2010058378A1/en not_active Ceased
- 2009-11-23 KR KR1020117014191A patent/KR101939964B1/ko not_active Expired - Fee Related
- 2009-11-23 RU RU2011125320/15A patent/RU2519722C2/ru active
- 2009-11-23 ES ES16191697T patent/ES2718731T3/es active Active
- 2009-11-23 US US13/130,456 patent/US9476880B2/en not_active Expired - Fee Related
- 2009-11-23 AU AU2009318813A patent/AU2009318813B2/en not_active Ceased
- 2009-11-23 CA CA2744434A patent/CA2744434C/en active Active
- 2009-11-23 EP EP20090761023 patent/EP2362943A1/en not_active Ceased
- 2009-11-23 CN CN200980155194.XA patent/CN102292637B/zh not_active Expired - Fee Related
-
2011
- 2011-05-19 IL IL212988A patent/IL212988A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009318813A1 (en) | 2011-07-14 |
| KR20110103965A (ko) | 2011-09-21 |
| KR101939964B1 (ko) | 2019-01-18 |
| AU2009318813B2 (en) | 2016-11-24 |
| KR20190006614A (ko) | 2019-01-18 |
| JP5438770B2 (ja) | 2014-03-12 |
| EP3141904A1 (en) | 2017-03-15 |
| CN102292637B (zh) | 2015-08-05 |
| EP2362943A1 (en) | 2011-09-07 |
| ES2718731T3 (es) | 2019-07-04 |
| RU2519722C2 (ru) | 2014-06-20 |
| WO2010058378A1 (en) | 2010-05-27 |
| CA2744434A1 (en) | 2010-05-27 |
| IL212988A0 (en) | 2011-07-31 |
| IL212988A (en) | 2014-08-31 |
| CN102292637A (zh) | 2011-12-21 |
| EP3141904B1 (en) | 2019-01-02 |
| US20110287455A1 (en) | 2011-11-24 |
| CA2744434C (en) | 2017-10-03 |
| JP2012509477A (ja) | 2012-04-19 |
| RU2011125320A (ru) | 2012-12-27 |
| US9476880B2 (en) | 2016-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY162697A (en) | Methods, devices and kits for detecting or monitoring acute kidney injury | |
| ZA200805787B (en) | Detection of cancer by elevated levels of BCL-2 | |
| MX2007014815A (es) | Metodos de inmunoanalisis mejorados. | |
| ATE438853T1 (de) | Diagnostische testvorrichtung | |
| NZ604873A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2009132058A3 (en) | Levels of bcma protein expression on b cells and use in diagnostic methods | |
| EP4235181A3 (en) | Biomarker detection process and assay of neurological condition | |
| ATE425266T1 (de) | Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten | |
| JP2012509477A5 (OSRAM) | ||
| NZ607703A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2006128192A3 (en) | Use of free circulating dna for diagnosis, prognosis, and treatment of cancer | |
| NZ619883A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| NZ600828A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2012075506A3 (en) | Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses | |
| AR063125A1 (es) | Ensayo elisa para la deteccion de vegf | |
| WO2010065781A3 (en) | Lateral flow strip assay with immobilized conjugate | |
| WO2008135862A3 (en) | Devices and methods for detecting analytes | |
| WO2010046443A3 (en) | Methods for detection and diagnosis of a bone or cartilage disorder | |
| WO2008027098A3 (en) | Biosensor for measurement of species in a body fluid | |
| NO20063898L (no) | Elektrokjemisk biosensor | |
| PE20141450A1 (es) | Ensayo de lisiloxidasa-homologo 2 y metodos de uso del mismo | |
| NZ594772A (en) | Diagnosis and prognosis of renal injury and renal failure using vitamin k dependent protein c | |
| WO2009020782A3 (en) | Oral fluid assays for the detection of heavy metal exposure | |
| NZ599773A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2008131261A3 (en) | Peptide biomarkers of cardiovascular disease |